MedTrace Logo

Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Surgery

NCT00373464 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2011-07-01

No results posted yet for this study

Summary

The aim of this trial is to compare if a single dose of oral etoricoxib 120 mg will have equal post-operative analgesic efficacy as an optimal regiment of intravenous ketorolac 30 mg + 30 mg during the first 18 hours (+/- 1 hour) after gynaecologic laparoscopic surgical procedures, where the need for post-operative opioid is expected.

Conditions

  • Hysterectomy
  • Tubal Excision
  • Ovariectomy
  • Postoperative Pain

Interventions

DRUG

etoricoxib

Sponsors & Collaborators

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • University of Oslo

    collaborator OTHER

  • Ullevaal University Hospital

    lead OTHER

Principal Investigators

  • Johan Ræder, Prof.MD,PhD · Ullevaal University Hospital

  • Harald Lenz, MD · Ullevaal University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Completion
2007-03-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00373464 on ClinicalTrials.gov